XML 44 R24.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Income Taxes | 12 Months Ended
--- | ---
Dec. 28, 2024
Income Tax Disclosure [Abstract] |
Income Taxes | Income Taxes Income before income taxes consists of the following:
| Year Ended
| December 28, 2024 |  | December 30, 2023 |  | December 31, 2022
| (In millions)
U.S. | $ | 2,369 |  |  | $ | 454 |  |  | $ | 2,093 |
Non-U.S. | (347) |  |  | 54 |  |  | (895) |
Total pre-tax income including equity income in investee | $ | 2,022 |  |  | $ | 508 |  |  | $ | 1,198 |
The income tax provision (benefit) consists of:
| Year Ended
| December 28, 2024 |  | December 30, 2023 |  | December 31, 2022
| (In millions)
Current: |  |  |  |  |
U.S. federal | $ | 1,338 |  |  | $ | 496 |  |  | $ | 1,191 |
U.S. state and local | 64 |  |  | 27 |  |  | 31 |
Non-U.S. | 142 |  |  | 150 |  |  | 161 |
Total | 1,544 |  |  | 673 |  |  | 1,383 |
Deferred: |  |  |  |  |
U.S. federal | (311) |  |  | (860) |  |  | (1,365) |
U.S. state and local | 6 |  |  | (29) |  |  | (26) |
Non-U.S. | (858) |  |  | (130) |  |  | (114) |
Total | (1,163) |  |  | (1,019) |  |  | (1,505) |
Income tax provision (benefit) | $ | 381 |  |  | $ | (346) |  |  | $ | (122) |
The table below displays the reconciliation between statutory federal income taxes and the total income tax provision (benefit).
| Year Ended
| December 28, 2024 |  | December 30, 2023 |  | December 31, 2022
| (In millions)
Statutory federal income tax expense at 21% | $ | 425 |  |  | $ | 107 |  |  | $ | 252 |
Tax effect from intercompany integration transaction | 373 |  |  | — |  |  | — |
Foreign rate detriment (benefit) | 153 |  |  | (11) |  |  | 195 |
Interest and penalty | 136 |  |  | 53 |  |  | 33 |
State income taxes, net of federal benefit | 22 |  |  | (2) |  |  | (3) |
Foreign-Derived Intangible Income (FDII) deduction | (275) |  |  | (185) |  |  | (261) |
Research credits | (232) |  |  | (169) |  |  | (241) |
GILTI and other foreign inclusion | (133) |  |  | (138) |  |  | (96) |
Stock-based and non-deductible compensation | (101) |  |  | (17) |  |  | (6) |
Other | 13 |  |  | 16 |  |  | 5 |
Income tax provision (benefit) | $ | 381 |  |  | $ | (346) |  |  | $ | (122) |
The Company recorded an income tax provision of $381 million and an income tax benefit of $346 million in 2024 and 2023, respectively, representing effective tax rates of 19% and (68)%, respectively. The increase in income tax provision in 2024 was primarily due to higher pre-tax income and a $373 million tax effect from an intercompany integration transaction. Beginning in 2022, provisions in the U.S. Tax Cuts and Jobs Act of 2017 require the Company to capitalize and amortize R&D expenditures rather than deducting the costs as incurred. The capitalization resulted in an increase in 2024 and 2023 taxable income which also increased the income eligible for the FDII tax benefit. As a part of the Xilinx acquisition and as a result of certain employment and operational commitments the Company has made in Singapore, the Company has been granted a Development and Expansion Incentive (DEI) that is effective through 2031. The DEI reduces the local tax on Singapore income from a statutory rate of 17% to 5% through 2031. Due to the current year pre-tax loss in Singapore, the Company did not receive any income tax or earnings per share benefit. Deferred income taxes reflect the net tax effects of tax carryovers and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the balances for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities as of December 28, 2024 and December 30, 2023 were as follows:
| December 28, 2024 |  | December 30, 2023
| (In millions)
Deferred tax assets: |  |  |
Capitalized R&D | $ | 2,892 |  |  | $ | 1,753 |
Net operating loss carryovers | 962 |  |  | 992 |
Accruals and reserves not currently deductible | 829 |  |  | 574 |
Federal and state tax credit carryovers | 679 |  |  | 660 |
Foreign R&D and investment tax credits | 579 |  |  | 597 |
Employee benefits not currently deductible | 334 |  |  | 302 |
Lease liability | 182 |  |  | 181 |
Foreign tax credits | 77 |  |  | 71 |
Other | 111 |  |  | 96 |
Total deferred tax assets | 6,645 |  |  | 5,226 |
Less: valuation allowance | (2,136) |  |  | (2,124) |
Total deferred tax assets, net of valuation allowance | 4,509 |  |  | 3,102 |
Deferred tax liabilities: |  |  |
Acquired intangibles | (3,614) |  |  | (3,104) |
GILTI | (222) |  |  | (524) |
Right-of-use assets | (182) |  |  | (175) |
Other | (152) |  |  | (135) |
Total deferred tax liabilities | (4,170) |  |  | (3,938) |
Net deferred tax assets (liabilities) | $ | 339 |  |  | $ | (836) |
During 2024, the Company executed an intercompany integration transaction and remeasured associated deferred taxes, resulting in increases to the deferred tax liability for acquisition-related intangibles and the deferred tax asset for Capitalized R&D, partially offset by a decrease in the deferred tax liability for GILTI. The movement in the deferred tax valuation allowance was as follows:
| December 28, 2024 |  | December 30, 2023 |  | December 31, 2022
| (In millions)
Balance at beginning of year | $ | 2,124 |  |  | $ | 2,078 |  |  | $ | 1,735 |
Charges to income tax expense and other accounts | 9 |  |  | 41 |  |  | 112 |
Acquisition-related | 3 |  |  | 5 |  |  | 231 |
Balance at end of year | $ | 2,136 |  |  | $ | 2,124 |  |  | $ | 2,078 |
Through the end of fiscal year 2024, the Company continued to maintain a valuation allowance of approximately $2.1 billion for certain federal, state, and foreign tax attributes. The federal valuation allowance maintained is due to limitations under Internal Revenue Code Section 382 or 383, separate return loss year rules, or dual consolidated loss rules. Certain state and foreign valuation allowance maintained is due to lack of sufficient sources of future taxable income. The Company’s U.S. federal and state net operating losses (NOLs) carryforwards as of December 28, 2024, were $134 million and $362 million, respectively. NOLs may be subject to limitations by the Internal Revenue Code and similar provisions. $27 million of U.S. federal NOLs will expire between 2025 and 2037, and $107 million of federal NOLs have no expiration date. State NOLs will expire at various dates through 2043. The difference between the amount of federal NOLs which are recorded on the Company’s Consolidated Balance Sheets as deferred tax assets and their related valuation allowance, and the amounts reported on the Company’s tax returns are the result of uncertain tax positions the Company has taken for which an income tax reserve has been recorded. The federal tax credits of $12 million will expire at various dates between 2037 and 2042. The state tax return credits of $804 million will expire at various dates between 2025 and 2039, except for the California R&D credit, which does not expire. The Company also has $620 million of credit carryforward in Canada that will expire between 2028 and 2044. A reconciliation of the Company's gross unrecognized tax benefits was as follows:
| December 28, 2024 |  | December 30, 2023 |  | December 31, 2022
| (In millions)
Balance at beginning of year | $ | 1,463 |  |  | $ | 1,361 |  |  | $ | 275 |
Increases for tax positions taken in the current year | 57 |  |  | 53 |  |  | 748 |
Increases for tax positions taken in prior years | 24 |  |  | 57 |  |  | 104 |
Decreases for tax positions taken in prior years | (18) |  |  | (8) |  |  | (12) |
Increases to tax positions taken in prior years through acquisitions | — |  |  | — |  |  | 252 |
Decreases for settlements with taxing authorities and statute of limitation lapses | (28) |  |  | — |  |  | (6) |
Balance at end of year | $ | 1,498 |  |  | $ | 1,463 |  |  | $ | 1,361 |
The amount of unrecognized tax benefits that would impact the effective tax rate if recognized was $1.3 billion, $1.3 billion and $1.2 billion as of December 28, 2024, December 30, 2023 and December 31, 2022, respectively. The Company had $298 million, $142 million and $81 million of accrued penalties and interest related to unrecognized tax benefits as of December 28, 2024, December 30, 2023 and December 31, 2022, respectively. As of December 28, 2024 and December 30, 2023, the Company had long-term income tax liabilities related to unrecognized tax benefits of $1.4 billion, recorded under Other long-term liabilities in the Company’s Consolidated Balance Sheets. The Company is subject to taxation in the U.S. and foreign jurisdictions. Earnings from non-U.S. activities are subject to local country income tax. The material jurisdiction in which the Company is subject to potential examination by the taxing authority is the United States, where tax years from 2008 are open for audit. Pre-acquisition Xilinx U.S. tax returns for fiscal years 2018 and 2019 are currently under audit by the IRS. It is possible the Company may have tax audits close in the next 12 months that could materially change the balance of the uncertain tax benefits; however, the timing of tax audit closures and settlements are highly uncertain. Under current U.S. tax law, the impact of future distributions of undistributed earnings that are indefinitely reinvested are anticipated to be subject to withholding taxes from local jurisdictions and non-conforming U.S. state jurisdictions. There were no cumulative undistributed earnings that are indefinitely reinvested that could be subject to withholding taxes as of December 28, 2024.

X
- References No definition available. + Details
Name: | us-gaap_IncomeTaxDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income tax. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 231 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 270 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 6.I.5.Q1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/740/tableOfContent Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 17 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 11.C) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration